Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. (Q53338455)
Jump to navigation
Jump to search
scientific article published in March 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. |
scientific article published in March 2000 |
Statements
Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. (English)
1 March 2000
196
2
253-256